GE HealthCare Technologies Inc. (GEHC) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — GEHC

Balance Sheet

(in billions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Cash & Equivalents	2.26	4.01	3.74	2.45	3.55	2.00	2.55	2.41	1.94	2.32
Inventory	2.35	2.30	2.28	2.16	2.12	2.02	1.99	2.13	2.26	2.26
Total Current Assets	10.43	11.89	11.31	9.74	10.64	8.81	9.37	9.47	9.24	9.60
Goodwill	15.06	13.44	13.42	13.37	13.14	13.12	12.93	12.91	12.93	12.92
Intangible Assets	1.83	1.09	1.14	1.14	1.13	1.20	1.17	1.33	1.42	1.49
Total Non-current Assets*	26.70	24.23	24.19	23.85	23.22	23.05	22.84	22.91	23.07	23.03
Total Assets	37.13	36.13	35.50	33.59	33.85	31.85	32.21	32.38	32.31	32.64
Accounts Payable	3.41	2.99	2.98	3.15	2.91	2.82	2.93	2.77	2.84	2.98
Short-term Debt	0.01	2.01	2.01	2.00	1.01	1.01	1.01	0.01	0.01	0.01
Total Current Liabilities	8.53	10.07	9.75	9.97	8.67	8.32	8.86	7.57	7.58	8.24
Long-term Debt	10.13	10.28	10.28	8.76	10.31	9.24	9.26	10.25	10.23	10.23
Total Non-current Liabilities*	17.70	15.83	15.80	14.20	16.67	15.54	15.75	17.51	17.41	17.50
Total Liabilities	26.23	25.91	25.55	24.17	25.34	23.86	24.61	25.08	24.99	25.74
Retained Earnings	5.65	4.71	4.30	3.81	2.56	2.10	1.69	0.94	0.58	0.19
Total Stockholder Equity	10.67	9.99	9.71	9.19	8.32	7.80	7.41	7.13	7.10	6.69

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Total Revenue	5.13	5.70	5.14	5.01	4.78	5.32	4.86	4.84	4.65	5.21	4.82	4.82	4.71
Cost of Revenue*	3.15	3.44	3.15	3.02	2.77	3.05	2.84	2.84	2.75	3.05	2.89	2.88	2.82
Gross Profit	1.98	2.26	1.99	1.99	2.01	2.28	2.03	2.00	1.90	2.16	1.94	1.94	1.89
Research & Development	0.35	0.32	0.29	0.30	0.34	0.34	0.32	0.33	0.32	0.32	0.32	0.30	0.27
Selling, General & Admin	1.12	1.11	1.05	1.03	1.04	1.13	1.03	1.07	1.04	1.15	1.00	1.07	1.06
Total Operating Expenses	1.46	1.43	1.34	1.33	1.38	1.47	1.35	1.40	1.36	1.47	1.32	1.37	1.33
Operating Income	0.52	0.83	0.65	0.65	0.63	0.80	0.68	0.61	0.54	0.69	0.62	0.57	0.56
Pretax Income	0.51	0.82	0.64	0.61	0.69	0.83	0.66	0.58	0.51	0.61	0.64	0.57	0.55
Tax Provision	0.09	0.22	0.18	0.11	0.10	0.10	0.17	0.14	0.12	0.19	0.25	0.14	0.16
Net Income	0.39	0.59	0.45	0.49	0.56	0.72	0.47	0.43	0.37	0.40	0.38	0.42	0.37
Basic EPS	0.85	1.29	0.98	1.06	1.23	1.58	1.03	0.94	0.82	0.89	0.82	0.92	0.42
Diluted EPS	0.85	1.28	0.98	1.06	1.23	1.58	1.02	0.93	0.81	0.89	0.82	0.91	0.41

* Derived from reported values

Cash Flow Statement

(in billions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Operating Cash Flow	0.29	1.05	0.94	0.09	0.25	0.91	1.04	(0.12)	0.42	--	0.65	(0.07)	0.47
Capital Expenditures	0.18	0.13	0.11	0.09	0.15	0.10	0.09	0.06	0.14	0.09	0.29	0.07	0.14
Free Cash Flow*	0.11	0.92	0.83	0.01	0.10	0.81	0.95	(0.18)	0.27	--	0.36	(0.14)	0.33
Investing Cash Flow	(2.50)	(0.27)	(0.15)	(0.22)	(0.41)	(0.24)	(0.14)	(0.35)	(0.19)	(0.09)	(0.12)	(0.08)	(0.27)
Financing Cash Flow	0.02	(0.29)	(0.16)	1.36	(0.29)	(1.28)	0.91	(0.06)	(0.15)	(0.90)	(0.02)	(0.23)	0.67

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Dividends Per Share	0.04	0.04	0.07	0.00	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.06